Tower Research Capital (TRC)’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,948
| Closed | -$54K | – | 6030 |
|
|
2020
Q4 | $54K | Sell |
2,948
-10,791
| -79% | -$197K | ﹤0.01% | 3061 |
|
|
2020
Q3 | $252K | Buy |
13,739
+10,889
| +382% | +$183K | ﹤0.01% | 2345 |
|
|
2020
Q2 | $43K | Buy |
+2,850
| New | +$40.7K | ﹤0.01% | 3170 |
|
|
2020
Q1 | – | Sell |
-130
| Closed | -$2K | – | 4339 |
|
|
2019
Q4 | $2K | Sell |
130
-1,073
| -89% | -$17.9K | ﹤0.01% | 3173 |
|
|
2019
Q3 | $18K | Buy |
+1,203
| New | +$16.2K | ﹤0.01% | 2559 |
|
|
2019
Q2 | – | Sell |
-939
| Closed | -$16K | – | 4617 |
|
|
2019
Q1 | $16K | Buy |
+939
| New | +$17K | ﹤0.01% | 2421 |
|
|
2018
Q4 | – | Sell |
-562
| Closed | -$11K | – | 4613 |
|
|
2018
Q3 | $11K | Buy |
+562
| New | +$11.5K | ﹤0.01% | 2733 |
|
|
2018
Q1 | – | Sell |
-453
| Closed | -$5K | – | 4110 |
|
|
2017
Q4 | $5K | Buy |
453
+101
| +29% | +$1.05K | ﹤0.01% | 2939 |
|
|
2017
Q3 | $4K | Sell |
352
-1,473
| -81% | -$13.9K | ﹤0.01% | 3437 |
|
|
2017
Q2 | $16K | Buy |
+1,825
| New | +$16.1K | ﹤0.01% | 1353 |
|
|
2016
Q3 | – | Sell |
-868
| Closed | -$10K | – | 4821 |
|
|
2016
Q2 | $10K | Buy |
868
+838
| +2,793% | +$13.5K | ﹤0.01% | 2859 |
|
|
2016
Q1 | $1K | Sell |
30
-101
| -77% | -$1.67K | ﹤0.01% | 3878 |
|
|
2015
Q4 | $3K | Sell |
131
-3,842
| -97% | -$81.2K | ﹤0.01% | 3571 |
|
|
2015
Q3 | $67K | Buy |
3,973
+3,743
| +1,627% | +$93.1K | 0.01% | 823 |
|
|
2015
Q2 | $9K | Sell |
230
-233
| -50% | -$7.52K | ﹤0.01% | 2838 |
|
|
2015
Q1 | $15K | Buy |
+463
| New | +$12.5K | ﹤0.01% | 2493 |
|
|
2014
Q4 | – | Sell |
-170
| Closed | -$4K | – | 4964 |
|
|
2014
Q3 | $4K | Buy |
+170
| New | +$3.46K | ﹤0.01% | 3497 |
|
Tower Research Capital (TRC)'s CBMG Position: Q1 2021 in Review
Tower Research Capital (TRC) sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 2,948 shares — an estimated $54K sold.
Tower Research Capital (TRC) first reported a position in CBMG in Q3 2014 and held it in 17 quarters. The position peaked at $252K in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.
- Tower Research Capital (TRC) reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,948 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $54K.
- Tower Research Capital (TRC) first reported a position in Cellular Biomedicine Group, Inc. in Q3 2014 and held it in 17 quarters.
- Tower Research Capital (TRC)'s Cellular Biomedicine Group, Inc. position peaked at $252K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.